News

Helsinki – June 8, 2021 – MVision will be releasing an important update to segmentation service that standardizes organ-at-risk contouring and automates segmentation in radiotherapy to streamline cancer treatment planning. The update is scheduled to take place between June 12th-June 13th. (more…)

Less than a year after the CE marking of MVision Segmentation Service 1.1, our team has obtained another one: The state-of-the-art solution is now also available with lymph nodes. With the ability to contour lymph nodes, we enter an era where AI algorithms actually help clinicians in every contouring step…

We are here to explore topics around AI in radiotherapy, share practical tips, and address questions as well as biases we with our partners come across in our daily work. Welcome to AI in RT 101 - first up some myths. The potential of AI in radiotherapy has been acknowledged…

The year has been an exceptional one, to say the least. It has also been a year of new growth for us at MVision AI. From successfully closing our second funding round to doubling the number of colleagues and usage volumes, we wrap up the year with gratitude. But before,…

We are happy to announce the publication of our first peer-reviewed paper. The retrospective multicenter study proves that using a general deep learning-based automated segmentation tool for CT images indeed saves time and improves consistency. The abstract of A Deep Learning-Based Automated CT Segmentation of Prostate Cancer Anatomy for Radiation…

It is always a great pleasure to welcome new partners to our global network! This time, we are happy to announce a partnership with OncoMed-Solutions in Eastern Europe and Russia. Through the agreement, the Swiss-based company assumes responsibility for the distribution of MVision’s segmentation services in the Eastern European territory.…

We are happy to announce a new partnership with DTA,S.L. in Iberia. Through the agreement, the Madrid-based company assumes responsibility for the distribution of MVision’s segmentation services in Spain and Portugal. “We are very excited to work with MVision as their product fits perfectly to our mission of making the most…

MVision AI OY, a Helsinki based startup company in the field of radiation oncology software services, announces the successful CE certification of all AI-based organ models. The latest version of its innovative cloud-based segmentation services offers now organ models for all major cancer sites. The different models can be used…

Helsinki-based MVision developed AI software focusing on radiation treatment planning. Clinical use of the software was deployed in two Finnish hospitals last week. Radiotherapy plays an important role in cancer treatment. For each cancer patient receiving radiation treatment, a detailed treatment plan is compiled to determine where and how radiotherapy…